The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Confirmed tumor response by molecular subtype in patients with metastatic breast cancer: Sub-analysis from a phase 3 clinical study comparing oral paclitaxel and encequidar to IV paclitaxel.
 
Gerardo Antonio Umanzor Funez
No Relationships to Disclose
 
Hope S. Rugo
Honoraria - Mylan; Puma Biotechnology
Consulting or Advisory Role - Samsung
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Daiichi Sankyo; Macrogenics; Merck; Mylan; Novartis; Pfizer
 
Jorge Umanzor
No Relationships to Disclose
 
Francisco Barrios
No Relationships to Disclose
 
Rosa Vasallo
No Relationships to Disclose
 
M Chivalan
No Relationships to Disclose
 
Suyapa A. Bejarano
Research Funding - Kinex; MSD ONCOLOGY
Travel, Accommodations, Expenses - Asofarma; Pfizer; Pfizer
 
Julio Roberto Ramirez
No Relationships to Disclose
 
Luis Enrique Fein
No Relationships to Disclose
 
Ruben Dario Kowalyszyn
Consulting or Advisory Role - Astellas Pharma; BMS Argentina; Merck Serono; MSD Oncology
Speakers' Bureau - BMS Argentina; Novartis
Research Funding - Astellas Pharma; AstraZeneca; BMS; Gemabiotech; Lilly; MSD Oncology; Nektar; Novartis; Poliphor; Roche
 
Hui Wang
Employment - Athenex
Stock and Other Ownership Interests - Athenex
 
David Cutler
Employment - Athenex
Stock and Other Ownership Interests - Athenex; Merck Sharp & Dohme